The Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size is expected to reach USD 38.90 Billion by 2030, at a CAGR of 42.55% during the forecast period 2021-2030. According to the kinetic and structural studies, isocitrate dehydrogenase inhibitors are either capable of binding to the alpha-KG/Isocitrate site and as such act as binding competitors.